SLU-PP-332 is a first-in-class ERRα (Estrogen-Related Receptor Alpha) agonist, discovered by researchers at Saint Louis University. It mimics the effects of endurance exercise by boosting mitochondrial function, fat oxidation, and aerobic capacity.

Peptides are gaining attention for their potential role in mental health, including depression treatment